The strategy you outline is another version of The Greater Fool Theory. I.e., you hope investors will bid up your cancer stock to lofty heights because they fail to fully recognize that six other biotech companies are pursuing the exact same cancer indication and four of these six companies have a drug that targets the same biological pathway as your company’s drug.
If this is how you expect to consistently make money in biotech investing, I wish you the best of luck.
Market Data 
Markets 
AI
